
Good candidates for Inspire Sleep Therapy are adults with moderate to severe obstructive sleep apnea who have tried and cannot tolerate CPAP therapy. Specifically, you must have an apnea-hypopnea index (AHI) between 15 and 65, a body mass index (BMI) of 35 or less, and no complete collapse of your airway during sleep studies. This article explains the key criteria and considerations for determining eligibility.
For many people, a restful night’s sleep feels out of reach due to obstructive sleep apnea (OSA). While CPAP is a common treatment, it doesn’t work for everyone. Inspire is an innovative, FDA-approved alternative designed to help you breathe freely and sleep peacefully.
Inspire is an FDA-approved implantable device that treats obstructive sleep apnea without masks, hoses, or external machines. This treatment works from inside your body to keep your airway open while you sleep. The entire system is controlled by a small, handheld remote, giving you complete control over your therapy.
The Inspire system consists of three components: a small generator implanted below your collarbone, a breathing sensor between your ribs, and a stimulation lead positioned near the nerve controlling your tongue. When you turn the device on with a handheld remote before bed, it senses your breathing patterns and gently stimulates your hypoglossal nerve.
This stimulation moves your tongue forward slightly with each breath, preventing airway collapse that can cause sleep apnea episodes. The result is a clear path for air, reducing or eliminating pauses in breathing and loud snoring associated with OSA.
While Inspire is a life-changing option for many, it is not suitable for every person with sleep apnea. A thorough evaluation is required to determine if this treatment aligns with your specific health profile and anatomy.
First, you need a confirmed diagnosis of obstructive sleep apnea through either an at-home sleep study or an in-lab sleep study. Your sleep study results must show moderate-to-severe OSA with specific breathing pattern characteristics.
The primary requirements for Inspire candidacy include:
Age 18 years or older
Body Mass Index (BMI) of 35 or less
Apnea-Hypopnea Index (AHI) between 15 and 65 events per hour
Inability to use or benefit from CPAP therapy
No complete concentric collapse at the soft palate level
Understanding who is a good candidate for Inspire Sleep Therapy also involves considering why this treatment might be recommended over other options.
Inspire therapy becomes a consideration when CPAP therapy fails despite genuine attempts to make it work. Common reasons patients seek this alternative include:
Claustrophobia from the mask
Skin irritation or pressure sores
Discomfort from the forced air
Mask discomfort
Air pressure intolerance
The inconvenience of traveling with the machine
Disturbance to a sleeping partner
Lifestyle incompatibility with CPAP use
The ideal Inspire candidate often shares these characteristics:
An active lifestyle that makes CPAP travel difficult
Side or stomach sleeping preference
Nasal breathing during sleep (not primarily mouth breathing)
Commitment to device activation nightly
Realistic expectations about gradual symptom improvement
Motivated to find a long-term solution for their sleep apnea
Just as important as knowing who is a good candidate is understanding who is not. Certain factors can make Inspire an unsuitable or unsafe option.
Certain conditions make Inspire therapy inappropriate or potentially dangerous:
Central or mixed sleep apnea with significant central components
Complete concentric collapse of the soft palate
Pregnancy or plans to become pregnant
Need for MRI scans above the neck
Implanted devices that may interact with Inspire
Significant cardiopulmonary disorders
Active, untreated psychiatric conditions affecting therapy compliance
Additionally, some patients have an airway that collapses in a pattern that Inspire cannot treat, which is determined during the evaluation.
BMI above 35 remains a firm cutoff because higher weight correlates with treatment failure. Patients must demonstrate the ability to operate the remote control and remember to activate the device nightly. Those with significant chronic sinusitis or nasal congestion may need treatment for these conditions first.
A special examination called a Drug-Induced Sleep Endoscopy (DISE) may be performed. This short procedure allows the doctor to see exactly how and where your airway is collapsing while you are asleep, confirming that Inspire therapy will be effective for your specific anatomy.
The only way to know for sure if Inspire is right for you is to schedule a consultation with an experienced ENT specialist.
Start by scheduling a consultation. Bring your recent sleep study results, CPAP usage data if available, and a list of what you’ve tried to make CPAP work. During a consultation, necessary evaluations can be performed.
Your evaluation will include reviewing your sleep history, examining your airway anatomy, and, if indicated, ordering additional testing. If you appear to be a good candidate based on this initial assessment, Drug-induced sleep endoscopy (DISE) may be recommended to visualize your specific airway collapse pattern while sedated. This outpatient procedure helps predict Inspire success by showing exactly how and where your airway closes during sleep.
Inspire Sleep Therapy offers hope for carefully selected patients with moderate-to-severe obstructive sleep apnea who cannot tolerate CPAP. Success depends on meeting specific medical criteria, including an appropriate AHI range, a BMI under 35, and the right type of airway collapse pattern. If you’ve struggled with CPAP despite genuine efforts and meet the eligibility requirements, Inspire Sleep Therapy could be a solution to restore your restful sleep.

About the Author
Vincent Pisciotta
Dr. Pisciotta brings decades of ENT expertise, with advanced training at LSU and MD Anderson Cancer Center. He is recognized for his leadership and contributions to otolaryngology.
